Stay updated on HMPL-523 in Lymphoma Patients Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.

Latest updates to the HMPL-523 in Lymphoma Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a recording/display version change without modifying the underlying clinical trial details.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check39 days agoChange Detected- Added keyword: B-cell chronic lymphocytic leukemia to the study page. This change does not affect core content or study parameters.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded 'Results Posted' and new site details including Bergamo, Italy. Expanded Dose Escalation and Dose Expansion sections with detailed study endpoint definitions (PFS, TTR, DOR, ORR, CBR) and scheduling; removed older endpoint descriptions and some prior location text.SummaryDifference5%

Stay in the know with updates to HMPL-523 in Lymphoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.